- June 26, 2019
- 2:00 PM EDT
June Session: Scoring PD-L1 in TNBC with the Ventana SP142 Assay
Ventana PD-L1 (SP142) IHC Assay is the first and only PD-L1 test that is FDA approved for Triple Negative Breast Carcinoma (TNBC). Roche Medical Affairs Pathologists Dr. Michael Lynch and Dr. Bharathi Vennapusa will give a power point presentation on the interpretation guide, followed by a slide review teaching you how to score SP142 in TNBC.